Clinical Applications of Cardiac Magnetic Resonance Imaging in Cardiology. Consensus Statement of the Eurasian Association of Cardiologists (EAC) (2026)
Open Access
- 30 September 2026
- journal article
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 3,p. 6-71
Abstract
This consensus document summarizes the current role of cardiovascular magnetic resonance (CMR) in contemporary cardiology practice. It integrates the latest evidence, international guideline recommendations, and practical experience regarding the use of CMR in the diagnosis and management of the most common cardiovascular diseases. Particular attention is given to the appropriate clinical indications for CMR, standardized imaging protocols, interpretation of imaging findings, and their impact on clinical decision-making and patient outcomes. The document reviews the application of CMR in ischemic heart disease, cardiomyopathies, myocarditis, inflammatory heart diseases, cardiac tumors, cardio-oncology, and congenital heart disease. Modern techniques for myocardial tissue characterization, including late gadolinium enhancement and parametric mapping, are discussed as essential tools for the non-invasive assessment of myocardial fibrosis, inflammation, infiltration, and viability. Special emphasis is placed on the practical use of CMR in complex clinical scenarios where imaging findings directly influence diagnosis, risk stratification, and therapeutic strategy. This consensus is primarily intended for practicing cardiologists but will also be of value to radiologists, cardiac surgeons, cardiovascular imaging specialists, and other healthcare professionals involved in the care of patients with cardiovascular disease. The authors hope that this document will promote the appropriate and wider implementation of CMR in routine clinical practice, ultimately improving diagnostic accuracy, patient management, and clinical outcomes.Keywords
This publication has 221 references indexed in Scilit:
- Diagnosis and Treatment of Acute MyocarditisJAMA, 2023
- Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial FibrillationJAMA, 2022
- Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseasesEuropean Journal of Heart Failure, 2021
- Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)European Journal of Heart Failure, 2020
- Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast AgentJAMA Internal Medicine, 2020
- MRI of patients with implanted cardiac devicesJournal of Magnetic Resonance Imaging, 2017
- Association Between MRI Exposure During Pregnancy and Fetal and Childhood OutcomesJAMA, 2016
- Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter AblationJAMA, 2014
- Interstudy variability in cardiac magnetic resonance imaging measurements of ventricular volume, mass, and ejection fraction in repaired tetralogy of fallot: A prospective observational studyJournal of Magnetic Resonance Imaging, 2013
- Claustrophobia during magnetic resonance imaging: Cohort study in over 55,000 patientsJournal of Magnetic Resonance Imaging, 2007